MESO Competitors & Alternatives

Compare Mesoblast Ltd with similar stocks in the same industry

Biotechnology

MESO

Main Stock
$12.47
-6.03%
Tradestie Score
33
Market Cap
$2.08B
Revenue Growth
390.7%
Analyst Upside
+196.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: mesenchymal stem cell therapy, allogeneic cell therapy
Major Customers 3
hospitals specialty clinics research institutions
Critical Suppliers 2
Lonza cell manufacturing partners
Direct Ecosystem Rivals 3

Top Competitors

219 stocks in Biotechnology
Company Price Market Cap P/E Score Action
IMCR Immunocore Holdings plc American Depositary Shares
$29.10
-2.81%
$1.81B - 47 Compare
ABCL AbCellera Biologics Inc. Common Shares
$11.19
-2.65%
$1.78B - 62 Compare
DYN Dyne Therapeutics, Inc. Common Stock
$16.68
-2.80%
$1.78B - 51 Compare
TWST Twist Bioscience Corporation Common Stock
$105.85
-5.15%
$1.77B - 52 Compare
VRDN Viridian Therapeutics, Inc. Common Stock
$30.22
-2.10%
$1.74B - 37 Compare
CLDX Celldex Therapeutics, Inc
$28.68
-0.52%
$1.68B - 55 Compare
MNKD Mannkind Corporation
$3.91
-5.33%
$1.65B - 36 Compare
EWTX Edgewise Therapeutics, Inc. Common Stock
$43.61
-5.05%
$1.63B 5.5 34 Compare
BHVN Biohaven Ltd.
$13.91
+0.62%
$1.57B - 42 Compare
VCEL Vericel Corporation
$57.27
+0.54%
$1.56B 90.3 35 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)

219 stocks in this industry